GlassScriptPhysician profile
Kelly Redlinger Garvin
NPI 1235659640
$4,371.10
in general payments reported to CMS, 2019-2025
38 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $769 · 2022: $302 · 2023: $511 · 2024: $1,040 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $636.51 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $541.24 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $443.01 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $390.11 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Dexcom, INC. | $275.16 | 2022-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $270.96 | 2020-2025 | |
| Lilly USA, LLC | $247.56 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astellas Pharma US INC | $129.60 | 2023-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.24 | 2023-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $102.10 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.67 | 2020-2025 | Jardiance |
| Stryker Corporation | $83.53 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Corcept Therapeutics | $76.20 | 2024-2025 | Korlym |
| Daiichi Sankyo INC. | $75.74 | 2024-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $75.18 | 2021-2024 | Trintellix |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $72.83 | 2024-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $70.64 | 2023-2024 | |
| Amgen INC. | $68.08 | 2023-2025 | Otezla, Repatha, Evenity |
| Merck Sharp & Dohme LLC | $67.94 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Inari Medical, INC. | $57.91 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $53.18 | 2021-2025 | |
| Dynavax Technologies Corporation | $45.36 | 2024-2025 | Heplisav-B |
| Tris Pharma INC | $39.78 | 2025 | Dyanavel Xr |
| Xeris Pharmaceuticals, INC. | $39.67 | 2021-2025 | Gvoke Hypopen |
| Corium, LLC | $39.13 | 2023 | Azstarys |
| Cvrx, INC. | $36.80 | 2024-2025 | Barostim Neo System |
| Avanir Pharmaceuticals, INC. | $32.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.87 | 2025 | |
| Almatica Pharma LLC | $20.94 | 2021 | |
| Amarin Pharma, INC. | $20.63 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.44 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.53 | 2024 | Nuedexta |
| Horizon Therapeutics Plc | $16.45 | 2021 | |
| Abbott Laboratories | $15.62 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $15.59 | 2021 | |
| Adlon Therapeutics L.P. | $15.42 | 2020 | |
| Supernus Pharmaceuticals, INC. | $12.54 | 2021 | |
| Organon LLC | $11.07 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Garvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.